1. Home
  2. TDOC vs DRUG Comparison

TDOC vs DRUG Comparison

Compare TDOC & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

N/A

Current Price

$5.29

Market Cap

841.2M

Sector

Health Care

ML Signal

N/A

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$80.76

Market Cap

856.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDOC
DRUG
Founded
2002
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
841.2M
856.4M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
TDOC
DRUG
Price
$5.29
$80.76
Analyst Decision
Hold
Strong Buy
Analyst Count
16
5
Target Price
$7.40
$124.00
AVG Volume (30 Days)
5.7M
73.1K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.74
N/A
Revenue Next Year
$1.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$23.18
52 Week High
$9.77
$123.75

Technical Indicators

Market Signals
Indicator
TDOC
DRUG
Relative Strength Index (RSI) 51.66 48.24
Support Level $4.44 $77.80
Resistance Level $5.49 $91.00
Average True Range (ATR) 0.27 4.77
MACD 0.12 -0.62
Stochastic Oscillator 80.02 40.88

Price Performance

Historical Comparison
TDOC
DRUG

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: